Skip to content
Screener

PROCEPT BioRobotics Corporation PRCT Q4 2025 Annual earnings

Reported February 25, 2026 · After market close

Revenue$76.4MMiss by $17.4M
EPS-$0.53Miss by $0.21
Revenue estimate$93.8M
EPS estimate-$0.32

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$101.1M
EPS estimate-$0.39

Financials

Q4 2025

Income statement

See full
Revenue$76.4M+11.9%
Gross profit$46.3M+6.0%
Operating income-$31.0M-57.5%
Net income-$29.8M-58.3%
EPS (diluted)-$0.53-55.9%

Balance sheet

See full
Cash & equivalents$6.3M-98.1%
Total debt$78.5M-2.2%
Total equity$365.9M-9.0%
Total assets$508.1M-4.9%

Cash flow

See full
Operating cash flow-$10.3M+68.1%
CapEx$1.9M+57.6%
Free cash flow-$12.2M+63.7%

Valuation & ratios

Profitability

See full
Gross margin63.7%+2.6pp
Operating margin-33.7%-6.0pp
Net margin-31%-6.0pp
FCF margin-18.9%-7.0pp

Returns & leverage

See full
Return on equity-24.9%-1.6pp
Debt / equity0.2×0.0×
Current ratio6.8×-2.2×

Segments

By product

See full
Handpieces and other consumables$40.0M+21.1%
Service$5.9M+51.0%

FAQ

When did PROCEPT BioRobotics Corporation report Q4 2025 earnings?
PROCEPT BioRobotics Corporation (PRCT) reported Q4 2025 earnings on February 25, 2026 after market close.
What were PROCEPT BioRobotics Corporation's Q4 2025 revenue and EPS?
PROCEPT BioRobotics Corporation reported revenue of $76.4M and eps of $-0.53 for Q4 2025.
Did PROCEPT BioRobotics Corporation beat estimates in Q4 2025?
Revenue missed the consensus estimate of $93.8M by $17.4M. EPS missed the consensus estimate of $-0.32 by $0.21.
How did PROCEPT BioRobotics Corporation's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 11.9% from $68.2M a year earlier and eps declined 51.4% from $-0.35.
Where can I find PROCEPT BioRobotics Corporation's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001588978-26-000002) and the 10-K periodic report (0001588978-26-000009) directly on SEC EDGAR. The filing index links above go to sec.gov.